Summary
By eliminating necessary safeguards for pregnant girls and women who undergo the dangerous mifepristone abortion drug regimen, the U.S. Food and Drug Administration failed to abide by its legal obligations to protect the health, safety, and welfare of girls and women.
Related Articles
Press Releases
-
Image
-
Image
-
Image
-
Image
-
Image
-
Image
-
Image
-
Image
-
Image
-
Image
-
Image
-
Image
-
Image
-
Image
-
Image
-
Image
-
Image
-
Image
-
Image
-
Image
-
Image
-
Image
-
Image
-
Image
-
Image
-
Image
Case Documents
Court
Title
Date
U.S. Supreme Court
2/26/2024
Trial Court
1/12/2024
U.S. Supreme Court
4/14/2023
U.S. Supreme Court
4/14/2023
U.S. Supreme Court
4/14/2023
Additional Resources
Case Profiles
Image
Erin Morrow Hawley
Senior Counsel, Vice President of Center for Life & Regulatory Practice
Erin Morrow Hawley serves as senior counsel and vice president of the Center for Life and Regulatory Practice at Alliance Defending Freedom.
Image
Erik Baptist
Senior Counsel, Director of the Center for Life
Erik Baptist serves as senior counsel and director of the Center for Life at Alliance Defending Freedom.